Expression of vascular endothelial growth factor (VEGF) in IgA nephropathy
Abstract
Background: Vascular endothelial growth factor (VEGF) is an important mediator involved in maintaining normal kidney function. Loss of normal or controlled secretion of VEGF following damage to the visceral epithelial cells could lead to alterations in endothelial cell function.This study was carried out to evaluate expression of VEGF in IgA nephropathy in order to look for potential diagnostic markers and predictive markers for progression towards CKD.
Methods: This retrospective record based cross sectional study was carried out on a total of 16 whole renal cell biopsy specimens. Following the diagnosis of IgA nephropathy, immunohistochemical techniques were used to evaluate the VEGF expression. The expression of VEGF was graded and evaluated specific for the type of IgA nephropathy.
Results: VEGF expression was positive in 6 specimens (37.5%). The type of glomerular involvement showing VEGF positivity was mesangial proliferative glomerulonephritis, minimal change disease (12.5%), post infectious glomerulonephritis (6.25%) and focal-segmental glomerulosclerosis (6.25%). All the specimens which showed VEGF positivity were showing well-defined areas with positive cells (25-50%).
Conclusion: Considering the high magnitude of VEGF expression, the present study has potentiated the need for evaluating the statistical significance in attributing VEGF to IgA nephropathy in a larger volume of specimens.
Downloads
References
2. Knoppova B, Reily C, Maillard N, Rizk DV, Moldoveanu Z, Mestecky J, et al. The Origin and Activities of IgA1-Containing Immune Complexes in IgA Nephropathy. Front Immunol. 2016;7:117.doi: 10.3389/ fimmu.2016.00117. eCollection 2016.
3. Schrijvers BF, Flyvbjerg A, De Vriese AS. The role of vascular endothelial growth factor (VEGF) in renal pathophysiology. Kidney Int. 2004;65(6):2003-2017. doi: https://doi.org/10.1111/j.1523-1755.2004.00621.x
4. Chacko B. IgA nephropathy in India: what we do know. Ren Fail. 2011;33(1):102-107. doi: 10.3109/08 86022X.2010.523486.
5. Namikoshi T, Satoh M, Horike H, Fujimoto S, Arakawa S, Sasaki T, et al. Implication of peritubular capillary loss and altered expression of vascular endothelial growth factor in IgA nephropathy. Nephron Physiol. 2006;102(1):p9-16. Epub 2005 Sep 20. doi:10. 1159/000088405
6. Alsaad KO, Herzenberg AM. Distinguishing diabetic nephropathy from other causes of glomerulosclerosis: an update. J Clin Pathol. 2007;60(1):18-26. doi:10. 1136/ jcp.2005.035592
7. Wallace E, Maillard N, Ueda H, Hall S, Fatima H, Novak J, Julian BA. Immune profile of IgA-dominant diffuse proliferative glomerulonephritis. Clinic Kid J. 2014; 7(5):479-483. doi: 10.1093/ckj/sfu090
8. Ferrara N. Role of vascular endothelial growth factor in regulation of physiological angiogenesis. Am J Physiol Cell Physiol. 2001;280(6):C1358-C1366. doi: 10. 1152/ajpcell.2001.280.6.C1358
9. Lim AKh. Diabetic nephropathy - complications and treatment. Int J Nephrol Renovasc Dis. 2014;7:361-81. doi: 10.2147/IJNRD.S40172. eCollection 2014.
10. Doi K, Noiri E, Fujita T. Role of vascular endothelial growth factor in kidney disease. Curr Vasc Pharmacol. 2010; 8(1):122-128. doi : 10.2174/1570161 10 790226606
11. Kim BS, Goligorsky MS. Role of VEGF in kidney development, microvascular maintenance and patho-physiology of renal disease. Korean J Intern Med. 2003;18(2):65-75. doi:10.3904/kjim.2003.18.2.65
12. Donderski R, Szczepanek J, Domagalski K, Tretyn A, Korenkiewicz J, Marszałek A. Analysis of relative expression level of VEGF (vascular endothelial growth factor), HIF-1α (hypoxia inducible factor 1α) and CTGF (connective tissue growth factor) genes in chronic glomerulonephritis (CGN) patients. Kidney Blood Press Res. 2013;38(1):83-91. doi: 10.1159/00035 5754. Epub 2014 Feb 22.
13. Zhai YL, Zhu L, Shi SF, Liu LJ, Lv JC, Zhang H. Elevated soluble VEGF receptor sFlt-1 correlates with endothelial injury in IgA nephropathy. PLoS One. 2014;9(7):e101779. doi:10.1371/journal.pone. 0101779. eCollection 2014.
14. Liu E, Morimoto M, Kitajima S, Koike T, Yu Y, Shiiki H, Nagata M, et al. Increased expression of vascular endothelial growth factor in kidney leads to progressive impairment of glomerular functions. J Am Soc Nephrol. 2007;18(7):2094-2104. Epub 2007 Jun 6. doi:10.1681/ASN.2006010075
OAI - Open Archives Initiative
